Control of human T cell proliferation by platelet-activating factor

Area of Science:

• Immunology
• Cell Biology

Background:

• Platelet-activating factor (PAF) is a phospholipid with known immunomodulatory functions.
• Understanding PAF's role in immune cell proliferation is crucial for immunology research.

Purpose of the Study:

• To investigate the impact of PAF on mitogen-stimulated proliferation of human peripheral blood mononuclear cells (PBMC) and T cell subsets.
• To determine the differential effects of PAF on CD4+ and CD8+ T cell proliferation.

Main Methods:

• Studied proliferation of PBMC, purified T cells, and T cell subsets (CD4+, CD8+) in response to varying PAF concentrations.
• Utilized lyso-PAF, indomethacin, and PAF receptor antagonists (BN 52021, SRI 63-675) to elucidate mechanisms.

Main Results:

• High PAF concentrations (5-10 microM) significantly suppressed proliferation of all studied cell populations.
• Low PAF concentrations (10(-14) to 10(-8) M) selectively stimulated CD4+ T cell proliferation but not CD8+ T cells.
• Indomethacin enhanced CD4+ proliferation, suggesting a role for PAF-induced PGE2 production by monocytes.

Conclusions:

• PAF exhibits dose-dependent effects on T cell proliferation, suppressing it at high concentrations and stimulating CD4+ cells at low concentrations.
• Monocyte-derived PGE2 may partially counteract the stimulatory effect of PAF on CD4+ T cells.
• Specific PAF receptor antagonists showed differential effects, indicating complex signaling pathways.